Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease
Authors:
Open Access
- 17 February 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1095132
Abstract
Introduction: Inflammation is a common unifying factor in experimental models of non-alcoholic fatty liver disease (NAFLD) progression. Recent evidence suggests that housing temperature-driven alterations in hepatic inflammation correlate with exacerbated hepatic steatosis, development of hepatic fibrosis, and hepatocellular damage in a model of high fat diet-driven NAFLD. However, the congruency of these findings across other, frequently employed, experimental mouse models of NAFLD has not been studied.Methods: Here, we examine the impact of housing temperature on steatosis, hepatocellular damage, hepatic inflammation, and fibrosis in NASH diet, methionine and choline deficient diet, and western diet + carbon tetrachloride experimental models of NAFLD in C57BL/6 mice.Results: We show that differences relevant to NAFLD pathology uncovered by thermoneutral housing include: (i) augmented NASH diet-driven hepatic immune cell accrual, exacerbated serum alanine transaminase levels and increased liver tissue damage as determined by NAFLD activity score; (ii) augmented methionine choline deficient diet-driven hepatic immune cell accrual and increased liver tissue damage as indicated by amplified hepatocellular ballooning, lobular inflammation, fibrosis and overall NAFLD activity score; and (iii) dampened western diet + carbon tetrachloride driven hepatic immune cell accrual and serum alanine aminotransferase levels but similar NAFLD activity score.Discussion: Collectively, our findings demonstrate that thermoneutral housing has broad but divergent effects on hepatic immune cell inflammation and hepatocellular damage across existing experimental NAFLD models in mice. These insights may serve as a foundation for future mechanistic interrogations focused on immune cell function in shaping NAFLD progression.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK099222, R01DK099222-02S1, R01DK099222-08S1, DK078392)
- U.S. Department of War
- American Diabetes Association (1-18-IBS-100, 1-19-PMF-019)
- American Heart Association (17POST33650045)
- National Institute of Allergy and Infectious Diseases (1F31AI169757-01)
This publication has 88 references indexed in Scilit:
- Naturally occurring hypothermia is more advantageous than fever in severe forms of lipopolysaccharide- and Escherichia coli-induced systemic inflammationAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational studyCritical Care, 2012
- Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human conditionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Cellular mechanism of insulin resistance in nonalcoholic fatty liver diseaseProceedings of the National Academy of Sciences, 2011
- Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionineClinical Science, 2011
- Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factorBMC Gastroenterology, 2010
- In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-αJournal of Clinical Investigation, 2009
- Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient dietJournal of Lipid Research, 2008
- Stressor-specific alterations in corticosterone and immune responses in miceBrain, Behavior, and Immunity, 2008
- Macrophage glucocorticoid receptors regulate Toll-like receptor 4–mediated inflammatory responses by selective inhibition of p38 MAP kinaseBlood, 2007